Abstract:The adipose tissue has long been thought to represent a passive source of triglycerides and fatty acids. However, extensive data have demonstrated that the adipose tissue is also a major endocrine organ that directly or indirectly affects the physiological functions of almost all cell types. Obesity is recognized as a risk factor for multiple systemic conditions, including metabolic syndrome, type 2 diabetes mellitus, sleep apnea, cardiovascular disorders, and many others. Obesity-related changes in the adipose tissue induce functional and structural changes in cardiac myocytes, promoting a wide range of cardiovascular disorders, including atrial fibrillation (AF). Due to the wealth of epidemiologic data linking AF to obesity, the mechanisms underlying AF occurrence in obese patients are an area of rich ongoing investigation. However, progress has been somewhat slowed by the complex phenotypes of both obesity and AF. The triad inflammation, oxidative stress, and mitochondrial dysfunction are critical for AF pathogenesis in the setting of obesity via multiple structural and functional proarrhythmic changes at the level of the atria. The aim of this paper is to provide a comprehensive view of the close relationship between obesity-induced oxidative stress, inflammation, and mitochondrial dysfunction and the pathogenesis of AF. The clinical implications of these mechanistic insights are also discussed.

What problem does this paper attempt to address?

This paper attempts to explore the complex pathophysiological link between obesity and atrial fibrillation (AF), especially to explain this link through the three aspects of inflammation, oxidative stress and mitochondrial dysfunction. Obesity not only affects heart structure and function, but also promotes the occurrence and development of atrial fibrillation through these three key factors: inflammation, oxidative stress and mitochondrial dysfunction. The author aims to provide a comprehensive view to explain how these pathological changes induced by obesity specifically lead to atrial fibrillation and discuss the significance of these mechanisms in clinical practice. ### Main concerns of the paper: 1. **The impact of obesity on the heart**: Obesity affects the heart through multiple pathways, including causing changes in heart structure and function, which increase the risk of atrial fibrillation. 2. **The role of inflammation**: Chronic inflammation related to obesity releases multiple pro - inflammatory cytokines (such as TNF - α, IL - 6, etc.), leading to electrical and structural remodeling of atrial tissue, thereby increasing the risk of atrial fibrillation. 3. **The impact of oxidative stress**: Oxidative stress caused by obesity damages cardiomyocytes and further promotes the development of atrial fibrillation. 4. **Mitochondrial dysfunction**: Mitochondrial dysfunction in cardiomyocytes caused by obesity affects energy metabolism, exacerbates damage to atrial tissue, and thus promotes the occurrence of atrial fibrillation. 5. **Clinical significance**: The paper also discusses the application of these mechanisms in clinical practice, providing new ideas for the prevention and treatment of atrial fibrillation. ### Main conclusions: - Obesity significantly increases the risk of atrial fibrillation through the three key factors of inflammation, oxidative stress and mitochondrial dysfunction. - These pathological changes not only promote the occurrence of atrial fibrillation, but may also form a self - sustaining cycle, further aggravating the condition. - Understanding these mechanisms is helpful for developing new treatment methods and improving the management of atrial fibrillation in obese patients. Through these studies, the author hopes to provide a deeper understanding for clinicians and researchers in order to better prevent and treat atrial fibrillation.

Oxidative Stress, Inflammation, and Mitochondrial Dysfunction: A Link between Obesity and Atrial Fibrillation

Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance

Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation

Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options

Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management

Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance

Exploring the Intricate Interplay Between Obesity and Atrial Fibrillation: Mechanisms, Management, and Clinical Implications

Oxidative stress and atrial fibrillation

Epicardial Adipose Tissue and Cardiac Arrhythmias: Focus on Atrial Fibrillation

Epicardial fat and atrial fibrillation: the perils of atrial failure

The effect of obesity, hypertension, diabetes mellitus, alcohol, and sleep apnea on the risk of atrial fibrillation

Paradoxical SERCA dysregulation contributes to atrial fibrillation in a model of diet-induced obesity

HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction

NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation

The Critical Roles of Proteostasis and Endoplasmic Reticulum Stress in Atrial Fibrillation

Obesity as a risk factor in atrial fibrillation and heart failure

Obesity phenotypes and their relationships with atrial fibrillation

Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications

Epicardial adipocytes in the pathogenesis of atrial fibrillation: An update on basic and translational studies

Multiple targets related to mitochondrial function unveiled by metabolomics and proteomics profiles of hearts from atrial fibrillation patients